Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.Target of the Week - SHP2 Antibodies
Feb 23, 2015
|
Dear Cancer Researcher, Abgent offers a portfolio of antibodies for the detection of SHP2 (PTPN11) in western blotting, immunohistochemistry and immunofluorescence. Abgent's anti-SHP2-Ab (Cat# AP8471e) has recently been used to detect the immunochemistry expression pattern in stage I-III colorectal carcinoma (CRC). SHP2 expression in CRC correlated to a good prognosis, indicating SHP2 tends to be a tumor suppressor in CRC. To find the right antibody for your research, please visit Abgent SHP2 Antibodies. |
 Polyclonal SHP2 AntibodyCat# AP8471A |
 Polyclonal SHP2 Antibody (Y546)Cat# AP8471e |
 Phospho-SHP2 Polyclonal AntibodyCat# AP3716a |
 PTPN11 Monoclonal AntibodyCat# AM1920a |
 |
 |
 |
Events
